Is Rivaroxaban Safe in Patients With Renal Dysfunction?
作者信息
Jin Eun-Sun
机构信息
Cardiovascular Center, Kyung Hee University Hospital at Gangdong, Seoul, Korea.
出版信息
Korean Circ J. 2025 Feb;55(2):132-133. doi: 10.4070/kcj.2024.0361. Epub 2024 Nov 20.
Abstract
摘要
相似文献
1
Is Rivaroxaban Safe in Patients With Renal Dysfunction?利伐沙班在肾功能不全患者中是否安全？
Korean Circ J. 2025 Feb;55(2):132-133. doi: 10.4070/kcj.2024.0361. Epub 2024 Nov 20.
2
Evaluation of clinical outcomes among nonvalvular atrial fibrillation patients treated with rivaroxaban or warfarin, stratified by renal function
.
Clin Nephrol. 2018 May;89(5):314-329. doi: 10.5414/CN109281.
3
Ischemic stroke, hemorrhage, and mortality in patients with non-valvular atrial fibrillation and renal dysfunction treated with rivaroxaban: sub-analysis of the EXPAND study.利伐沙班治疗非瓣膜性心房颤动和肾功能不全患者的缺血性卒中、出血及死亡率：EXPAND研究的亚组分析
Heart Vessels. 2021 Sep;36(9):1410-1420. doi: 10.1007/s00380-021-01810-5. Epub 2021 Mar 16.
4
Use of rivaroxaban attenuates renal function impairment in patients with atrial fibrillation: insights of the EMIR study.利伐沙班可减轻房颤患者的肾功能损害：来自 EMIR 研究的观察。
Eur J Clin Invest. 2022 Sep;52(9):e13788. doi: 10.1111/eci.13788. Epub 2022 Apr 14.
5
Rivaroxaban Plus Aspirin in Patients With Vascular Disease and Renal Dysfunction: From the COMPASS Trial.利伐沙班联合阿司匹林治疗血管疾病合并肾功能不全患者：来自 COMPASS 试验。
J Am Coll Cardiol. 2019 May 14;73(18):2243-2250. doi: 10.1016/j.jacc.2019.02.048.
6
Atrial fibrillation and chronic kidney disease: focus on rivaroxaban.心房颤动与慢性肾脏病：聚焦于利伐沙班
J Comp Eff Res. 2015 Nov;4(6):651-64. doi: 10.2217/cer.15.44. Epub 2015 Sep 21.
7
Impact of renal function on ischemic stroke and major bleeding rates in nonvalvular atrial fibrillation patients treated with warfarin or rivaroxaban: a retrospective cohort study using real-world evidence.肾功能对华法林或利伐沙班治疗的非瓣膜性心房颤动患者缺血性卒中和大出血发生率的影响：一项使用真实世界证据的回顾性队列研究。
Curr Med Res Opin. 2017 Oct;33(10):1891-1900. doi: 10.1080/03007995.2017.1339674. Epub 2017 Jul 11.
8
Evaluating Renal Benefits of Rivaroxaban Versus Vitamin K Antagonists in Atrial Fibrillation: A Systematic Review and Meta-analysis of Real-world Evidence.评估利伐沙班与维生素K拮抗剂在心房颤动中的肾脏获益：基于真实世界证据的系统评价和荟萃分析
Eur Cardiol. 2024 Jun 13;19:e05. doi: 10.15420/ecr.2024.07. eCollection 2024.
9
Model-Based Risk Prediction of Rivaroxaban with Amiodarone for Moderate Renal Impaired Elderly Population.基于模型的利伐沙班与胺碘酮用于中度肾功能不全老年人群的风险预测。
Cardiovasc Drugs Ther. 2023 Jun;37(3):605-609. doi: 10.1007/s10557-021-07266-z. Epub 2021 Oct 27.
10
Rivaroxaban for treatment of intraventricular thrombus in Chagas disease.利伐沙班用于治疗恰加斯病的脑室内血栓。
J Cardiol Cases. 2015 Dec 8;13(3):75-77. doi: 10.1016/j.jccase.2015.10.010. eCollection 2016 Mar.
本文引用的文献
1
A Real-World, Prospective, Observational Study of Rivaroxaban on Prevention of Stroke and Non-Central Nervous Systemic Embolism in Renally Impaired Korean Patients With Non-Valvular Atrial Fibrillation: XARENAL.利伐沙班预防韩国非瓣膜性心房颤动肾损害患者卒中及非中枢神经系统栓塞的真实世界、前瞻性观察研究：XARENAL研究
Korean Circ J. 2025 Feb;55(2):121-131. doi: 10.4070/kcj.2024.0154. Epub 2024 Oct 23.
2
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).2024年欧洲心脏病学会（ESC）心房颤动管理指南，与欧洲心胸外科学会（EACTS）联合制定。
Eur Heart J. 2024 Sep 29;45(36):3314-3414. doi: 10.1093/eurheartj/ehae176.
3
Impact of Renal Function on Outcomes With Edoxaban in Real-World Patients With Atrial Fibrillation.肾功能对真实世界房颤患者应用依度沙班的结局影响。
Stroke. 2018 Oct;49(10):2421-2429. doi: 10.1161/STROKEAHA.118.021387.
4
Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation.在新发和现患房颤患者中，肾小球滤过率（GFR）各范围下直接口服抗凝剂的风险和获益。
Clin J Am Soc Nephrol. 2018 Aug 7;13(8):1144-1152. doi: 10.2215/CJN.13811217. Epub 2018 Jul 12.
5
Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) trial analysis.达比加群酯与华法林在伴有基线肾功能异常的房颤患者中的疗效和安全性比较：RE-LY（随机评估长期抗凝治疗）试验分析。
Circulation. 2014 Mar 4;129(9):961-70. doi: 10.1161/CIRCULATIONAHA.113.003628. Epub 2013 Dec 9.
6
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.利伐沙班与华法林用于非瓣膜性心房颤动。
N Engl J Med. 2011 Sep 8;365(10):883-91. doi: 10.1056/NEJMoa1009638. Epub 2011 Aug 10.
Zotero 插件